Free Trial
→ Why this tiny stock may move before the SpaceX IPO drops (From Behind the Markets) (Ad)tc pixel Free CWEB Stock Alerts

Charlotte's Web (CWEB) Competitors

Charlotte's Web logo
C$0.54 0.00 (0.00%)
As of 06/12/2026 04:00 PM Eastern
Compare

CWEB vs. CPH, ACB, FIRE, SUGR, and EPI

Should you buy Charlotte's Web stock or one of its competitors? MarketBeat compares Charlotte's Web with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Charlotte's Web include Cipher Pharmaceuticals (CPH), Aurora Cannabis (ACB), Supreme Cannabis (FIRE), SugarBud Craft Growers (SUGR), and ESSA Pharma (EPI). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Charlotte's Web compare to Cipher Pharmaceuticals?

Cipher Pharmaceuticals (TSE:CPH) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

2.3% of Cipher Pharmaceuticals shares are held by institutional investors. Comparatively, 1.6% of Charlotte's Web shares are held by institutional investors. 42.0% of Cipher Pharmaceuticals shares are held by insiders. Comparatively, 11.3% of Charlotte's Web shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cipher Pharmaceuticals has a net margin of 60.82% compared to Charlotte's Web's net margin of -74.93%. Cipher Pharmaceuticals' return on equity of 25.69% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Cipher Pharmaceuticals60.82% 25.69% 7.90%
Charlotte's Web -74.93%-2,056.41%-17.25%

Cipher Pharmaceuticals has a beta of 1.104631, meaning that its stock price is 10% more volatile than the broader market. Comparatively, Charlotte's Web has a beta of 0.768745, meaning that its stock price is 23% less volatile than the broader market.

Cipher Pharmaceuticals presently has a consensus price target of C$17.00, suggesting a potential upside of 4.23%. Given Cipher Pharmaceuticals' stronger consensus rating and higher probable upside, equities research analysts clearly believe Cipher Pharmaceuticals is more favorable than Charlotte's Web.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cipher Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Charlotte's Web
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Cipher Pharmaceuticals has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cipher PharmaceuticalsC$50.94M8.13C$11.41MC$1.1913.71
Charlotte's WebC$48.79M2.99-C$25.55M-C$0.23N/A

In the previous week, Cipher Pharmaceuticals' average media sentiment score of 0.00 equaled Charlotte's Web'saverage media sentiment score.

Company Overall Sentiment
Cipher Pharmaceuticals Neutral
Charlotte's Web Neutral

Summary

Cipher Pharmaceuticals beats Charlotte's Web on 13 of the 13 factors compared between the two stocks.

How does Charlotte's Web compare to Aurora Cannabis?

Aurora Cannabis (TSE:ACB) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

In the previous week, Aurora Cannabis had 10 more articles in the media than Charlotte's Web. MarketBeat recorded 10 mentions for Aurora Cannabis and 0 mentions for Charlotte's Web. Charlotte's Web's average media sentiment score of 0.00 beat Aurora Cannabis' score of -0.28 indicating that Charlotte's Web is being referred to more favorably in the news media.

Company Overall Sentiment
Aurora Cannabis Neutral
Charlotte's Web Neutral

Aurora Cannabis currently has a consensus target price of C$7.67, indicating a potential upside of 80.39%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, research analysts clearly believe Aurora Cannabis is more favorable than Charlotte's Web.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Charlotte's Web
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aurora Cannabis has a net margin of -12.13% compared to Charlotte's Web's net margin of -74.93%. Aurora Cannabis' return on equity of -7.25% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-12.13% -7.25% -1.87%
Charlotte's Web -74.93%-2,056.41%-17.25%

Aurora Cannabis has a beta of 0.174133, suggesting that its stock price is 83% less volatile than the broader market. Comparatively, Charlotte's Web has a beta of 0.768745, suggesting that its stock price is 23% less volatile than the broader market.

4.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 1.6% of Charlotte's Web shares are owned by institutional investors. 11.3% of Charlotte's Web shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Charlotte's Web has lower revenue, but higher earnings than Aurora Cannabis. Charlotte's Web is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$320.59M0.82-C$44.16M-C$2.14N/A
Charlotte's WebC$48.79M2.99-C$25.55M-C$0.23N/A

Summary

Aurora Cannabis beats Charlotte's Web on 10 of the 16 factors compared between the two stocks.

How does Charlotte's Web compare to Supreme Cannabis?

Charlotte's Web (TSE:CWEB) and Supreme Cannabis (TSE:FIRE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

In the previous week, Charlotte's Web's average media sentiment score of 0.00 equaled Supreme Cannabis'average media sentiment score.

Company Overall Sentiment
Charlotte's Web Neutral
Supreme Cannabis Neutral

1.6% of Charlotte's Web shares are held by institutional investors. 11.3% of Charlotte's Web shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Supreme Cannabis has a net margin of 0.00% compared to Charlotte's Web's net margin of -74.93%. Supreme Cannabis' return on equity of 0.00% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Charlotte's Web-74.93% -2,056.41% -17.25%
Supreme Cannabis N/A N/A N/A

Supreme Cannabis has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Supreme Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charlotte's WebC$48.79M2.99-C$25.55M-C$0.23N/A
Supreme CannabisC$53.29M0.00-C$23.65M-C$0.03N/A

Summary

Supreme Cannabis beats Charlotte's Web on 6 of the 9 factors compared between the two stocks.

How does Charlotte's Web compare to SugarBud Craft Growers?

SugarBud Craft Growers (CVE:SUGR) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, SugarBud Craft Growers' average media sentiment score of 0.00 equaled Charlotte's Web'saverage media sentiment score.

Company Overall Sentiment
SugarBud Craft Growers Neutral
Charlotte's Web Neutral

SugarBud Craft Growers has a net margin of 2.11% compared to Charlotte's Web's net margin of -74.93%. SugarBud Craft Growers' return on equity of 10.07% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
SugarBud Craft Growers2.11% 10.07% 5.13%
Charlotte's Web -74.93%-2,056.41%-17.25%

SugarBud Craft Growers has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than SugarBud Craft Growers, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SugarBud Craft GrowersC$662.89M0.36C$12.12MC$1.407.15
Charlotte's WebC$48.79M2.99-C$25.55M-C$0.23N/A

0.4% of SugarBud Craft Growers shares are held by institutional investors. Comparatively, 1.6% of Charlotte's Web shares are held by institutional investors. 30.2% of SugarBud Craft Growers shares are held by company insiders. Comparatively, 11.3% of Charlotte's Web shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SugarBud Craft Growers has a beta of 2.768948, suggesting that its stock price is 177% more volatile than the broader market. Comparatively, Charlotte's Web has a beta of 0.768745, suggesting that its stock price is 23% less volatile than the broader market.

Summary

SugarBud Craft Growers beats Charlotte's Web on 9 of the 11 factors compared between the two stocks.

How does Charlotte's Web compare to ESSA Pharma?

ESSA Pharma (CVE:EPI) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

1.6% of Charlotte's Web shares are owned by institutional investors. 11.3% of Charlotte's Web shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

ESSA Pharma has higher earnings, but lower revenue than Charlotte's Web. ESSA Pharma is trading at a lower price-to-earnings ratio than Charlotte's Web, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ESSA PharmaN/AN/AN/A-C$0.99N/A
Charlotte's WebC$48.79M2.99-C$25.55M-C$0.23N/A

ESSA Pharma has a net margin of 0.00% compared to Charlotte's Web's net margin of -74.93%. ESSA Pharma's return on equity of 0.00% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
ESSA PharmaN/A N/A N/A
Charlotte's Web -74.93%-2,056.41%-17.25%

In the previous week, ESSA Pharma's average media sentiment score of 0.00 equaled Charlotte's Web'saverage media sentiment score.

Company Overall Sentiment
ESSA Pharma Neutral
Charlotte's Web Neutral

Summary

Charlotte's Web beats ESSA Pharma on 5 of the 8 factors compared between the two stocks.

Get Charlotte's Web News Delivered to You Automatically

Sign up to receive the latest news and ratings for CWEB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CWEB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CWEB vs. The Competition

Export
MetricCharlotte's WebDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$146.10MC$2.39BC$6.52BC$12.19B
Dividend YieldN/A2.94%2.67%6.19%
P/E Ratio-2.355.0124.0036.94
Price / Sales2.991,642.95514.3610.45
Price / Cash8.9010.1827.4882.29
Price / Book-5.7310.6110.544.47
Net Income-C$25.55MC$20.27BC$3.57BC$299.09M
7 Day Performance-5.26%-0.80%0.60%0.65%
1 Month Performance-8.47%6.97%1.56%-0.08%
1 Year Performance332.00%16.05%25.42%41.90%

Charlotte's Web Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CWEB
Charlotte's Web
N/AC$0.54
flat		N/A+332.0%C$146.10MC$48.79MN/A164
CPH
Cipher Pharmaceuticals
N/AC$16.00
-3.1%		C$17.00
+6.3%		+24.6%C$419.21MC$50.94M13.455
ACB
Aurora Cannabis
2.1611 of 5 stars		C$4.28
-6.8%		C$9.25
+116.1%		-46.7%C$271.39MC$373.12MN/A1,073
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29MN/A400
SUGR
SugarBud Craft Growers
N/AC$10.00
-9.1%		N/A-21.9%C$240.69MC$662.89M7.1544

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:CWEB) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel